TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the t…
Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared TRACON Pharmaceuticals, Inc. (TCON) to it's peer group.
Peer Group
MNPR KRON XOMA RZLT CADL ENOB CYCN BTTX PMVP TPST LRMR ANEB HSTO ACXP IKT ANTX SIOX MIRO VINC
Compare Together
Loading...